Jesús
Bañales Asurmendi
Catedrático de Universidad
Hospital Universitario de Donostia
San Sebastián, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Donostia (160)
2024
-
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1
JHEP Reports, Vol. 6, Núm. 1
-
Comparative performance of methylation DNA markers, brushing cytology, and FISH in diagnosing malignant biliary strictures
Hepatology
-
Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease
Annals of Surgical Oncology, Vol. 31, Núm. 10, pp. 6495-6503
-
Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA
Hepatology (Baltimore, Md.), Vol. 79, Núm. 6, pp. 1279-1292
-
Fibroblast-Derived Lysyl Oxidase Increases Oxidative Phosphorylation and Stemness in Cholangiocarcinoma
Gastroenterology, Vol. 166, Núm. 5, pp. 886-901.e7
-
Letter to the Editor: Serum Identification of At-Risk MASH: The Metabolomics-Advanced Steatohepatitis Fibrosis Score (MASEF)
Hepatology
-
Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis
Hepatology, Vol. 79, Núm. 2, pp. 269-288
-
Recommendations on maximising the clinical value of tissue in the management of patients with intrahepatic cholangiocarcinoma
JHEP Reports, Vol. 6, Núm. 6
-
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer
Cell Reports, Vol. 43, Núm. 3
-
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
Biomedicine and Pharmacotherapy, Vol. 180
-
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)
Hepatology, Vol. 79, Núm. 1, pp. 135-148
-
Stratified analyses refine association between TLR7 rare variants and severe COVID-19
Human Genetics and Genomics Advances, Vol. 5, Núm. 4
-
TGFβ-induced long non-coding RNA LINC00313 activates Wnt signaling and promotes cholangiocarcinoma
EMBO Reports, Vol. 25, Núm. 3, pp. 1022-1054
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology, Vol. 59, Núm. 7, pp. 586-597
2023
-
A TGFβ-ECM-integrin signaling axis drives structural reconfiguration of the bile duct to promote polycystic liver disease
Science translational medicine, Vol. 15, Núm. 713, pp. eabq5930
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans
Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 709-726
-
Aberrant fucosylation sustains the NOTCH and EGFR/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma
Hepatology (Baltimore, Md.), Vol. 78, Núm. 6, pp. 1742-1754
-
Cirrhosis is associated with lower serological responses to COVID-19 vaccines in patients with chronic liver disease
JHEP Reports, Vol. 5, Núm. 5
-
Combined Inhibition of Smoothened and the DNA Damage Checkpoint WEE1 Exerts Antitumor Activity in Cholangiocarcinoma
Molecular cancer therapeutics, Vol. 22, Núm. 3, pp. 343-356